NIH-funded research Fellowship grant

Understanding how T cells fight tuberculosis without needing specific antigens

Official title: The role of antigen-independent T cell activation in controlling M. tuberculosis infection

Funded at University of Washington · NIH-11126526 · Data updated 2026-11-12

This study is looking at how certain immune cells called T cells help fight tuberculosis (TB) infections, especially in adults who are more likely to get sick, to find new ways to create better vaccines against TB.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startFebruary 1, 2024
Project endJanuary 31, 2027
Funding year2025
Award (this year)$48,974
NIH project number5F31AI179043-02
Project IDNIH-11126526 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation include adults and children who are at risk of tuberculosis infection or have been exposed to the bacteria.

Less likely to help

Patients who are not at risk for tuberculosis or those who have already been effectively treated for the infection may not benefit from this research.

What this research studies

This research investigates the role of T cells in controlling tuberculosis (TB) infections, particularly focusing on how some T cells can be activated without specific antigens. The study aims to explore both classical T cells, which respond to peptide antigens, and nonclassical T cells, which can recognize non-peptide antigens. By examining these mechanisms, the research seeks to uncover new strategies for developing effective vaccines against TB, especially for adults who are at higher risk of pulmonary disease. Patients may be involved in studies that assess their immune responses to TB and the effectiveness of potential new vaccines.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective vaccines against tuberculosis, potentially saving lives and reducing disease transmission.

How similar studies have gone: Previous research has shown promise in understanding T cell responses to infections, but this specific approach focusing on antigen-independent activation is relatively novel.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Winter, Cassandra — University of Washington
  • Study coordinator: Winter, Cassandra

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.